Abstract. 3b-hydroxysteroid dehydrogenase (3b-HSD) is known to be involved in steroid production and/or metabolism and to be expressed in many tissues including adrenal cortex. Expression of this enzyme has also been elucidated in human cardiovascular system but its details remain largely unknown. Therefore, in this study, we examined the status of 3b-HSD in postmortem human aorta utilizing RT-PCR and immunohistochemical analysis. Both mRNAs and immunoreactivity for the enzyme were detected predominantly in female aorta, and in those with mild atherosclerotic changes. In addition, immunohistochemical study demonstrated that immunoreactivity for 3b-HSD was detected in vascular smooth muscle cells (VSMCs) of aorta. These findings all indicated that steroidogenesis via 3b-HSD may occur in VSMCs of human aorta, possibly related to gender differences and/or the degree of atherosclerosis.
3b-HYDROXYSTEROID dehydrogenase (3b-HSD), which converts pregnenolone to progesterone, is wellknown to be essential for production of steroid hormones including progesterone, mineralcorticoids, glucocorticoids, androgens, and estrogens in classical steroidogenic tissues [1] [2] [3] . In addition, the activity of this enzyme is demonstrated not only in classical steroidogenic tissues, but also in many peripheral tissues including human central nervous system [1, [4] [5] [6] . The presence of this enzyme in the cardiovascular system has been also documented in previously published reports [1, [6] [7] [8] . Especially, it has been demonstrated that there were relatively abundant levels of 3b-HSD activity in hearts of experimental animals [7, 8] . Expression of 3b-HSD was also reported in human vascular smooth muscle cells (VSMCs) of artery and vein [1, 7] . However, details regarding their expression in human cardiovascular system have not been examined.
Therefore, in this study, we first examined the localization and relative abundance of 3b-HSD in human aorta using RT-PCR and immunohistochemical analysis in order to evaluate the possible expression of this enzyme in human aorta.
Materials and Methods

Specimens of human aorta
Human abdominal aorta were collected at the time of autopsy performed at Tohoku University Hospital, Sendai, Japan, within two hours postmortem from 28 subjects (12 male, 16 female, mean 54.0 ± 4.7 years old). These patients examined consist of 10 cancer cases (digestive, respiratory and urinary tract) and 18 non-cancer cases (ischemic heart disease, respiratory and renal failure). None of these patients were on oral contraceptive or hormone replacement therapy. The Ethics Committee at Tohoku University School of Medicine approved the research protocol for this study (The Ethics Committee Approval number 2001-014). These specimens for RT-PCR study were collected from the areas adjacent to the specimens for histopathological study. The adventitia and fat tissues surrounding the aorta were immediately and carefully removed using clean surgical scissors and forceps at the time of autopsy. Following this procedure, these specimens were immediately frozen in liquid nitrogen and stored at -80°C until use for RT-PCR study. In addition, the samples were categorized into two groups based on the degree of atherosclerosis. The classification of atherosclerosis defined by the American Heart Association (AHA) in 1995 was employed in this study in order to semi-quantify the degree of atherosclerotic changes in each specimen, utilizing macroscopic findings at the time of autopsy and subsequent microscopic findings [9, 10] . This classification was based on the fact that in the groups with advanced atherosclerotic changes, clinical complications may develop suddenly compared to those with early atherosclerotic changes [9, 10] . In this study, with regard to the degree of atherosclerotic changes, aortic specimens were classified into the following two categories of atheroma score: mild atherosclerosis, corresponding to group I to III in the AHA classification; advanced atherosclerosis, corresponding to group IV to VI in the AHA classification (18 mild atherosclerosis, 10 severe atherosclerosis).
Real-time polymerase chain reaction (PCR)
The procedures have been previously reported in detail [5] . Total RNA was extracted by homogenizing frozen tissue samples in 1 mL TRIzol reagent (Invitrogen, Carlsbad, CA) followed by a phenol-chloroform phase extraction and isopropanol precipitation. All RNA samples were quantified by spectrophotometry and stored at -80°C until processed for reverse transcription (RT). The SUPERSCRIPT Preamplification system RT kit (Gibco-BRL, Grand Island, NY) was employed in the synthesis and amplification of complementary DNA (cDNA). cDNA was synthesized from total RNA (2 mg) using 25 ng/mL Oligo (dT) [12] [13] [14] [15] [16] [17] [18] Primer (Life Technologies, Inc., Gaithersburg, MD) on a PTC-200 Peltier Thermal Cycler DNA Engine (MJ Research, Inc., Watertown, MA). In order to test the presence of genomic DNA contamination, we performed the RT step in the absence of SUPERSCRIPT TM II RNase H -Reverse Transcriptase (Gibco-BRL) followed by PCR. RT-PCR products lacking reverse transcriptase in the initial RT step were run on an ethidiumbromide stained 2% agarose gel. No band was observed in these samples (data not shown). The resulting cDNA was used as a template for real-time polymerase chain reaction (PCR). Real-time PCR was carried out with the Light Cycler System (Roche Diagnostics GmbH, Mannheim, Germany) using the DNA binding dye SYBR Green I (Roche Diagnostics GmbH) for the detection of PCR products. A 35-cycle amplification profile consisted of denaturation at 94°C for 15 sec, annealing at 55°C for 10 sec, and extension at 72°C for 10 sec. The primers have been previously reported [5] . The primers were located in two different exons of each gene to avoid amplification of any contaminating genomic DNA. As a positive control, adrenal gland was used. Negative control experiments lacked cDNA substrate to check for the presence of exogenous contaminant DNA. No amplified products were detected under these conditions.
Primary antibody
Rabbit polyclonal antibody for 3b-HSD was employed in this study [11] . The property of this antibody and the application to immunohistochemistry in the human adrenal gland has been described previously in detail [11] .
Immunohistochemistry
Details of immunohistochemical procedures were previously described [11] . Immunohistochemical analyses were performed employing the streptavidin-biotin amplification method using a Histofine Kit (Nichirei Co., Tokyo, Japan). After deparaffinization, sections were treated with 0.3% hydrogen peroxidase in methanol for 30 min at room temperature. Normal goat serum (1%) was applied to the sections for 30 min at room temperature and primary antibody was reacted to the sections for 18 h at 4°C. The dilutions of primary antibodies used in our study were 1 : 1000. Sections were subsequently incubated with biotinylated antimouse immunoglobulin for 30 min, followed by exposure to peroxidase-conjugated streptavidin for 30 min at room temperature. Immunoreactivity was detected by immersing the tissue sections in 3,3'-diaminobenzidine (DAB) solution (1 mM DAB, 50 mM Tris-HCl buffer (pH 7.6), 10 mM sodium azide, and 0.006% hydrogen peroxidase). Methyl green was used as a nuclear coun-terstain. Normal rabbit IgG was used instead of the primary antibodies as negative controls and no specific immunoreactivity was detected in these tissue sections.
Statistical analysis
Values for all results are shown as mean ± standard error of means (SEM). Analysis of an expression status of mRNAs for the enzymes was evaluated in a cross-table using the c 2 -test. P-value less than 0.05 was considered significant in this study.
Results
RT-PCR analysis
RT-PCR products corresponding to their expected size for 3b-HSD (181 bp) were detected in 11 cases of human aorta (Fig. 1) . Of these 11 cases, 10 were females (10/11, 90.9%), and one was male (1/11, 9.1%) (P = 0.0037) ( Table 1 ). In addition, among these 11 cases, 10 were associated with mild atherosclerotic changes (10/11, 90.9%), and only one was that with severe atherosclerotic change (1/11, 9.1%) (P = 0.0180) ( Table 1 ). The sequence of the amplified PCR products for 3b-HSD in the human aorta was demonstrated to be consistent with that of 3b-HSD type II. However, there was no significant correlation between ages and expression of these mRNAs (Table 1) . Immunohistochemistry of the enzymes 3b-HSD immunoreactivity was predominantly detected in VSMCs of the media in all the specimens expressing these mRNAs. On the other hand, its immunoreactivity was not demonstrated in all the specimens that did not express its mRNAs. Fig. 2 shows a representative illustration of an abdominal aorta specimen obtained from a 43 year-old woman positive for 3b-HSD.
Discussion
Results of our present study demonstrated that the presence of 3b-HSD in human aorta, and that the expression may be influenced by differences of gender and the degree of atherosclerosis.
We could not perform exact quantitative RT-PCR of these enzymes mRNAs expression levels in these samples due to several reasons connected with the experiments, but these expression levels were at least less than 10% compared to those of adrenal gland based on relative strength of product bands using densitometer. These findings are consistent with a previous report [1] .
Steroid hormone is synthesized and secreted by ovaries, placenta, and adrenal glands. However, progesterone is also synthesized in non-reproductive tissues such as the central nervous system [1, [4] [5] [6] . Both steroidogenic endocrine glands and local synthesis are currently considered to contribute to the overall store of progesterone present in the brain and in human peripheral nerves. In addition, progesterone production in situ via 3b-HSD is considered to exert very important effects on the nervous system, such as the formation of myelin sheaths and regulation of myelin formation by influencing gene expression in peripheral nerves [12] . Results of our present study also suggest that local synthesis of progesterone may possibly contribute to its local action in the human aorta in which progesterone receptor has been reported to be present [13] , especially in female aorta, as in the human nervous system. 3b-HSD immunoreactivity was reported to be present in VSMCs of rat abdominal aorta [1] , which is consistent with results of our present study. These results all indicated that VSMCs in human aorta are not only targets of progesterone but also actively produce the steroid hormone in situ.
In our present study, the expression of 3b-HSD was more prevalent in female than in male aorta. It has been reported that the amounts of steroidogenic enzymes related to in situ estrogen production were significantly higher in female aorta than that in male aorta [10, 14] . Results of our present study also indicated that this intracrine mechanism enhances or facilitates steroid hormone effects in human aorta especially in female.
3b-HSD was reported to be expressed in ovaries, placenta, and adrenal glands, and important for production of progesterone in these tissues. However, 3b-HSD was also reported to be expressed in nonreproductive tissues such as the central nervous system, and important for production of progesterone in neurons and glial cells in brain, spinal cord and peripheral nerves [15] . Both steroidogenic endocrine glands and local synthesis are currently considered to contribute to the pool of progesterone present in brain and peripheral nerves. We previously demonstrated in situ estrogen synthesis in human aorta, especially in female aorta [10] . It has also been reported that progesterone plays an important role in athero-protection in human VSMCs via progesterone receptors (PRs) [16] , in the same fashion as estrogen via estrogen receptors (ERs). Results of our present study also suggest the importance of local synthesis of progesterone in the human aorta, especially in female aorta for athero-protection, as in human nervous system. In addition, we previously reported that expression levels of in situ estrogen synthesizing and/or metabolizing enzymes may be significantly associated with the degree of atherosclerotic changes in female aorta, which may be related to cytokines produced in situ in human atherosclerotic lesions [10] . Previous reports also documented that some cytokines and hormones were involved in regulation of 3b-HSD expression in breast cancer and/or testis [17, 18] . These may explain an association between 3b-HSD expression and degrees of atherosclerotic changes in human aorta. In addition, 3b-HSD expression in aorta may also be influenced by factors such as cytokines. However, it awaits further examination, including the determination of what cytokines are important for 3b-HSD expression.
